menu toggle

Insights

Perspective, tips, and resources for moving health forward

All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health
AmerisourceBergen

How to forge stronger working relationships with payers

Warren Dunn
AmerisourceBergen
March 2023

Manufacturers

The essential guide to drug commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2023

Manufacturers

Evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

David Senior
AmerisourceBergen
October 2022
Reimbursement models for CGT

Manufacturers

Improve outcomes and reduce costs for emerging therapies

AmerisourceBergen
October 2022
vaccines on top of US dollars

Manufacturers

Maintain an agile copay program in a changing policy environment

AmerisourceBergen
September 2022

Elevate Provider Network fights to prohibit GER, BER, and DIR Recoupments

Peter Kounelis
Peter Kounelis; Beth Lea; Shaun Henry; Tracy Armstrong
AmerisourceBergen
August 2022
Cropped shot of a pharmacist using a digital tablet in a chemist

Manufacturers

Innovative agreements: Exploring alternative payment models

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2022
innovative agreements

Manufacturers

Navigating reimbursement and access challenges for novel cell and gene therapies

Amanda OHora
July 2022
Business meeting

Manufacturers

Differentiate your product with FormularyDecisions®

Inverted color AmerisourceBergen icon
Xcenda
April 2022
Differentiate your product with FormularyDecisions

Pharmacies

Five benefits of an innovative PSAO

Gold Eneyo, PharmD; Phyllis Houston, MSOL ; Peter Kounelis, R.Ph.
AmerisourceBergen
March 2022

Manufacturers

Commercializing cell and gene therapies in Canada

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2022

Cell and gene therapies are currently at the forefront of scientific innovation. They hold great promise for patients suffering from a range of serious ailments.

Pharmacies

Podcast: Investing in independents

Peter Kounelis
Peter Kounelis, R.Ph.
AmerisourceBergen
January 2022

Pharmacies

Executive Q&A: Investing in independent pharmacy

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2022

Manufacturers

Working with government entities to advance access, affordability, and supply chain stability

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2021

Manufacturers

Essential skills for outsourced field solutions teams

Inverted color AmerisourceBergen icon
AmerisourceBergen
November 2021

Manufacturers

Building your field reimbursement and access team: The translational experience and skills that matter most

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2021

Manufacturers

eBook: Bringing innovation to market with digital therapeutics

Inverted color AmerisourceBergen icon
Lash Group
August 2021

Pharmacies

What pharmacies should know about DIRs, GERs, and BERs

Tim Jones
Tim Jones; Beth Lea
AmerisourceBergen
August 2021

Manufacturers

Digital innovation in patient support

Inverted color AmerisourceBergen icon
Innomar Strategies
August 2021

Manufacturers

What manufacturers need to know about reimbursement and patient support for cell and gene therapies

Ana Stojanovska; Myra Reinhardt
Biopharma Services
July 2021

Manufacturers

Navigating the payer landscape for digital therapeutics

Inverted color AmerisourceBergen icon
Lash Group
June 2021

Manufacturers

Patient support for digital therapeutics: Do's and don'ts for designing your program

Inverted color AmerisourceBergen icon
Lash Group
June 2021

Manufacturers

Work worth doing: Innovative field solutions

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2021

Manufacturers

Work worth doing: FormularyDecisions

Laurie Fazio
Xcenda
May 2021

Pharmacies

Getting reimbursed for the COVID-19 vaccine: What pharmacies need to know

Inverted color AmerisourceBergen icon
Good Neighbor Pharmacy
May 2021

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
Strategic partnerships for unlocking product potential ebook

Manufacturers

How to make the most of integrated commercialization solutions

Glen Martin headshot
Glen Martin
AmerisourceBergen
March 2021
AmerisourceBergen manufacturer commercialization strategies

Manufacturers

Buy-and-bill vs. self-administered: Field services remove barriers across access points

Rod Bryant
Rod Bryant, MS; MarSha Lewers
March 2021

Physician Practices

Healthcare payer trends in 2021

Christie Smith; Kristy McGowan
March 2021
Black female doctor looks at iPad

Manufacturers

Pharma in the field: Barrett's story

Inverted color AmerisourceBergen icon
Xcenda
March 2021

Manufacturers

Webinar: uptake or heartbreak with biosimilars? Progress and perspectives

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2021
Market access professionals

Manufacturers

Pre-launch checklist: What to look for in a commercialization partner

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2021

Manufacturers

Checklist: Four things to look for in a field services partner

Inverted color AmerisourceBergen icon
Xcenda
February 2021
xcenda field services working on project

Manufacturers

Launching field services in the midst of COVID-19

Inverted color AmerisourceBergen icon
Xcenda
February 2021

Manufacturers

Case study: an innovative field reimbursement program expands patient access

Inverted color AmerisourceBergen icon
Xcenda
January 2021

Manufacturers

Evaluating the modern field reimbursement and access program: key considerations

Inverted color AmerisourceBergen icon
Xcenda
December 2020
field-services-patient-access-meeting

Manufacturers

Pharma in the field: Heather's story

Inverted color AmerisourceBergen icon
Xcenda
December 2020
Doctor talking to patient

Manufacturers

Webinar: the growing utilization of copay accumulator programs

Corey Ford
Corey Ford, MHA; Dale Hanna
Xcenda
December 2020
lash group copay accumulator program

Manufacturers

Pharma in the field: Ashley's story

Inverted color AmerisourceBergen icon
Xcenda
November 2020
Doctor talking to patient

Manufacturers

Pharma in the field: Tierra's story

Inverted color AmerisourceBergen icon
Xcenda
November 2020

Health Systems

Biosimilars: Patents, policy, and reimbursement

Sean McGowan; Steve Miller; David Senior
AmerisourceBergen
October 2020

Manufacturers

Solving access, reimbursement, and PAP awareness problems

Inverted color AmerisourceBergen icon
Xcenda
August 2020
Male doctor speaking to patient on a tablet

Physician Practices

How to thrive with telemedicine

AmerisourceBergen icon
IntrinsiQ Specialty Solutions
August 2020
Doctor looks at laptop and takes notes

Manufacturers

Distant But Engaged: Transitioning to Virtual Training

Inverted color AmerisourceBergen icon
Xcenda
May 2020

Manufacturers

Video: Removing Barriers for Biosimilars

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2020

Manufacturers

How Digital Innovation Drives Improved Market Access Strategies

Inverted color AmerisourceBergen icon
Xcenda
July 2019

In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?

Manufacturers

Managing the Growing Expansion of Copay Accumulators

Corey Ford
Corey Ford, MHA
Xcenda
March 2019

Manufacturers

Medicare Part B: Do Providers Choose Treatment Based on Payment?

Inverted color AmerisourceBergen icon
Xcenda
January 2019

What does Medicare claims data reveal about physician-administered drugs? An Xcenda survey reveals whether physicians choose treatment based on how much they're reimbursed.

Pharmacies

Delivering Care Beyond Prescriptions: A Marketplace Opportunity for Independent Pharmacies

Brian Nightengale
Brian Nightengale
AmerisourceBergen
December 2018

The high-touch, high-quality, personalized care independent pharmacies provide creates a unique value proposition in a healthcare market where more chronically ill patients need accessible care. As payers are prioritizing improved patient outcomes and a reduction in overall healthcare costs, they need to also consider new reimbursement models for these pharmacy services, a framework under which independent pharmacies are uniquely positioned to excel.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Ana Stojanovska
Biopharma Services
June 2018

An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Ana Stojanovska
Biopharma Services
June 2018

An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.

Manufacturers

Insight Series: Value of Patient Support Programs for Specialty Medications in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
May 2018

Manufacturers

Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2018
Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

Manufacturers

Rethinking Reimbursement and Patient Support Following Medical Innovation

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2018

How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?

Manufacturers

Information Exchange With Payers and Providers

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2018

What information do payers and providers want from pharma?

Manufacturers

What Do Payers Think About Digital Health Technologies

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2017

How are payers thinking about apps, wearables and other digital health technologies?

Manufacturers

The Route to Market Access in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
September 2017

Understanding the unique considerations for reimbursement in the Canadian pharmaceutical market.

Manufacturers

Commercializing Cell and Gene Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2017

Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.

Physician Practices

Plugging Profit Leaks

Inverted color AmerisourceBergen icon
Alana Vaughn
ION Solutions
November 2016

Like a slowly dripping faucet or an improperly insulated window, gaps and inefficiencies in a business allow profits to seep out over time. Even one leak—while seemingly small—can have damaging effects on a company’s financial health. Oncology practices are no different.